Clinical Trial Update: Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a reduced-dose atazanavir in HIV-1 infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)

Snippet

Sponsor: Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED